Literature DB >> 22124320

Atrial fibrillation: Is dabigatran cost-effective compared with warfarin in patients with AF?

Alexandra King.   

Abstract

Entities:  

Year:  2011        PMID： 22124320     DOI： 10.1038/nrcardio.2011.175

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses.

Authors:  Joshua Pink; Steven Lane; Munir Pirmohamed; Dyfrig A Hughes
Journal:  BMJ       Date:  2011-10-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.